Non-Surgical Options For Hip Osteoarthritis In Ospina Medical – New York, NY
Can Hip Pain From Osteoarthritis Be Treated Without Surgery?
Pain is a leading symptom of hip osteoarthritis and often occurs more frequently than joint stiffness or limited mobility.1 If you’ve been told your hip pain is due to osteoarthritis and that joint replacement is the only solution, it may be worthwhile to explore all available care options.
Hip osteoarthritis involves the gradual breakdown of the surfaces where the bones of the hip joint meet. Procedures using interventional orthobiologics have been used to help reduce pain and support the body’s natural healing processes, offering a less invasive alternative to surgery, often with shorter recovery times and fewer associated risks.
| Regenexx-SD | Surgery | |
|---|---|---|
| Return to Daily Routine | 2 to 5 days | 6+ weeks |
| Return to Sports | 3 to 6 months | 1 year |
| Recovery | Brace, up to 6 weeks PT | Crutches, brace, extensive, no driving, 3 to 6 months PT |
| Pain Management | Mostly over-the-counter pain medication (days) | Prescription pain medication for weeks (weeks) |
| General Anesthesia | No | Yes |
| Keep Your Hip Joint | Yes | No |
635 Madison Ave
Suite 1301
New York, NY 10022
Request an Appointment
Call to Schedule Schedule OnlineClinic Hours
| Sunday | Closed |
| Monday | 9AM–5PM |
| Tuesday | 9AM–5PM |
| Wednesday | 9AM–5PM |
| Thursday | 9AM–5PM |
| Friday | 9AM–5PM |
| Saturday | Closed |
How Does The Regenexx Approach Work?
Regenexx developed a specialized approach to orthopedic care known as Interventional Orthopedics. Procedures using Regenexx injectates involve advanced image guidance to precisely deliver bone marrow concentrate, containing mesenchymal stem cells, directly to areas within the hip joint that require support.2-3
This concentrate may help promote the body’s natural ability to repair damaged tissue, contributing to improved joint stability, function, and mobility over time.4
Am I a candidate?
What Are the Risks of Hip Replacement Surgery and Other Treatments?
Hip replacement and resurfacing procedures are major interventions that often involve significant recovery periods. These surgeries typically require months of physical therapy, along with ongoing discomfort as the body adjusts and the joint gradually regains mobility and strength.
Potential risks associated with joint replacement include complications related to anesthesia, such as stroke or heart attack, as well as infection, blood clots, pseudotumor formation, prosthetic failure, and reactions to metal components. Additionally, joint replacements may not be permanent, and some patients require revision procedures over time.5-6
While many individuals choose surgery, hoping to return to a more active lifestyle, outcomes can vary. A 2016 meta-analysis of 17 clinical trials found no statistically significant increase in physical activity during the first year following a primary hip replacement.
Pharmaceutical pain management also has limitations. Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of cardiovascular issues, while opioid medications carry a high potential for dependency. Steroid injections, though sometimes used for symptom relief, are also associated with notable risks.7-10
At Ospina Medical, your evaluation may include a real-time assessment of joint function using ultrasound to visualize the internal structures of the hip. This motion-based approach helps identify what may be contributing to discomfort, how joint function is impacted, and the likely source of the issue.
Based on the findings, a personalized treatment plan will be developed to address your specific condition. Recommended options may include one or more of the following Regenexx injectates:
- Regenexx-SD Injectate: A patented protocol utilizing bone marrow concentrate that contains mesenchymal stem cells.
- Regenexx-SCP Injectate: A proprietary formulation of platelet-rich plasma (PRP) with higher concentration than bedside centrifuge methods.
- Regenexx-PL Injectate: A refined PRP derivative known as platelet lysate, designed to deliver a rapid and focused release of growth factors.
Webinar: Managing Hip Osteoarthritis Without Surgery
Join Chris Centeno, M.D., founder of Regenexx, for a free educational webinar exploring how the Regenexx approach may offer a nonsurgical option for addressing hip pain caused by arthritis, potentially with less downtime compared to traditional surgery.
In this session, you’ll learn:
- How do procedures using bone marrow concentrate and platelet-rich plasma (PRP) compare to surgical and other conventional treatment options
- What to expect before, during, and after Regenexx procedures
- Answers to commonly asked questions about orthobiologic treatments and how they may support joint health
FAQs
Hip osteoarthritis involves the gradual breakdown of joint tissue, leading to reduced function and mobility over time. This condition may develop due to a range of factors, including inflammation, genetics, prior hip injuries, infections, or long-term joint use.
While hip arthritis is most commonly seen in individuals in their 60s or 70s, its onset can occur earlier, depending on joint structure, body weight, and physical activity levels.
In some individuals, particularly during the early stages, hip arthritis may first appear as joint stiffness or reduced range of motion. As the condition progresses and joint degeneration increases, pain often becomes more noticeable over time.
Yes, many degenerative changes in the hip can be detected through MRI imaging. In the video below, Chris Centeno, M.D., highlights three key indicators of arthritis commonly seen on a hip MRI.
Hip resurfacing is often perceived as a less invasive alternative to traditional hip replacement, largely because it preserves more of the natural bone. However, this does not always mean fewer risks.
In a standard hip replacement, both the ball and socket of the joint are removed and replaced with prosthetic components, typically made of metal, ceramic, or a combination, secured with a stem that extends into the femur’s marrow cavity.
In contrast, hip resurfacing involves reshaping the natural head of the femur rather than removing it. A metal cap is placed over the bone, preserving more of the thighbone and leading some to view the procedure as less invasive. Still, studies have shown that hip resurfacing may carry increased risks, including a higher chance of femoral neck fracture, larger surgical incisions, formation of pseudotumors, earlier failure of the implant, and concerns about metal debris entering the bloodstream.11-12
Request an Appointment
References
1. Trouvin AP, Perrot S. Pain in osteoarthritis. Implications for optimal management. Joint Bone Spine. 2018 Jul;85(4):429-434. doi: 10.1016/j.jbspin.2017.08.002. Epub 2017 Sep 6. PMID: 28889010. Sep 6. PMID: 28889010.
2. Centeno CJ. Efficacy and Safety of Bone Marrow Concentrate for Osteoarthritis of the Hip; Treatment Registry Results for 196 Patients. J Stem Cell Res Ther 2014;04(10). doi:10.4172/2157-7633.1000242.
3. Friedlis MF, Centeno CJ. Performing a Better Bone Marrow Aspiration. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):919-939. doi: 10.1016/j.pmr.2016.06.009. PMID: 27788908.
4. Centeno CJ, Kisiday J, Freeman M, Schultz JR. Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: A case study. Pain Physician. 2006 Jul;9(3):253-6.
5. Lalmohamed A, Vestergaard P, Cooper C, de Boer A, Leufkens HG, van Staa TP, de Vries F. Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort study. Stroke. 2012 Dec;43(12):3225-9. doi: 10.1161/STROKEAHA.112.668509. Epub 2012 Nov 6. PMID: 23132782.
6. Harding P, Holland AE, Delany C, Hinman RS. Do activity levels increase after total hip and knee arthroplasty? Clin Orthop Relat Res. 2014 May;472(5):1502-11. doi: 10.1007/s11999-013-3427-3. Epub 2013 Dec 19. PMID: 24353051; PMCID: PMC3971219.
7. How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up Evans JT, Evans JP, Walker RW, Blom AW, Whitehouse MR, Sayers A. How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up. Lancet. 2019;393(10172):647-654. doi:10.1016/S0140-6736(18)31665-9
8. Withers TM, Lister S, Sackley C, Clark A, Smith TO. Is there a difference in physical activity levels in patients before and up to one year after unilateral total hip replacement? A systematic review and meta-analysis. Clin Rehabil. 2017;31(5):639-650. doi:10.1177/0269215516673884
9. Sakaguchi M, Tanaka T, Fukushima W, Kubo T, Hirota Y; Idiopathic ONF Multicenter Case-Control Study Group. Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head: a nationwide multicenter case-control study in Japan. J Orthop Sci. 2010;15(2):185-191. doi:10.1007/s00776-009-1439-3
10. Ravi B, Escott BG, Wasserstein D, et al. Intraarticular hip injection and early revision surgery following total hip arthroplasty: a retrospective cohort study. Arthritis Rheumatol. 2015;67(1):162-168. doi:10.1002/art.38886
11. Hjorth MH, Mechlenburg I, Soballe K, et al. Higher prevalence of mixed or solid pseudotumors in metal-on-polyethylene total hip arthroplasty compared with metal-on-metal total hip arthroplasty and resurfacing hip arthroplasty. J Arthroplasty, 2018;33:2279–2286. doi:10.1016/j.arth.2018.02.011.
12. Oxblom A, Hedlund H, Nemes S, et al. Patient-reported outcomes in hip resurfacing versus conventional total hip arthroplasty: a register-based matched cohort study of 726 patients. Acta Orthop. 2019;90:318-323. doi:10.1080/17453674.2019.1604343.
